Literature DB >> 9228669

A model of orthotopic murine bladder (MBT-2) tumor implants.

F Jiang1, X M Zhou.   

Abstract

We produced a model of orthotopic transplantation in C3H/He mice by transplanting MBT-2 cells. A single-cell suspension of 1.0 x 10(5) MBT-2 cells/0.02 ml was successfully injected into the submucosal layer of the bladder, with an incidence of 100% after four experimental weeks. Inoculated tumor grew expansively into the bladder cavity from the bladder submucosa and invaded the serosa and the surrounding tissue. This model more closely resembled the characteristics of human bladder tumor when compared to other bladder cancer models. The results of the histological observation, electron microscopic examination and DNA content analysis by flow cytometry showed that the transplanted carcinoma maintained the biologic characteristics of the primary tumor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228669     DOI: 10.1007/bf00941979

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  9 in total

1.  Methods to assess anticancer immune responses in orthotopic bladder carcinomas.

Authors:  Randy F Sweis
Journal:  Methods Enzymol       Date:  2019-10-24       Impact factor: 1.600

2.  Single-Cell Analyses of a Novel Mouse Urothelial Carcinoma Model Reveal a Role of Tumor-Associated Macrophages in Response to Anti-PD-1 Therapy.

Authors:  Dongbo Xu; Li Wang; Kyle Wieczorek; Yali Zhang; Zinian Wang; Jianmin Wang; Bo Xu; Prashant K Singh; Yanqing Wang; Xiaojing Zhang; Yue Wu; Gary J Smith; Kristopher Attwood; Yuesheng Zhang; David W Goodrich; Qiang Li
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

3.  Animal models for bladder cancer: The model establishment and evaluation (Review).

Authors:  Ning Zhang; Dongyang Li; Jialiang Shao; Xiang Wang
Journal:  Oncol Lett       Date:  2015-01-23       Impact factor: 2.967

4.  Enhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice.

Authors:  Han-Ning Huang; Venugopal Rajanbabu; Chieh-Yu Pan; Yi-Lin Chan; Jyh-Yih Chen; Chang-Jer Wu
Journal:  Mar Drugs       Date:  2015-05-21       Impact factor: 5.118

5.  Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.

Authors:  Soon-Ja Kim; Ho Kyung Seo; Hye-Hyun Seo; Sang-Jin Lee; Jong Kyou Kwon; Tae-Jin Lee; Byung Hoon Chi; In Ho Chang
Journal:  J Korean Med Sci       Date:  2014-02-27       Impact factor: 2.153

6.  Current animal models of bladder cancer: Awareness of translatability (Review).

Authors:  Jie Ding; Ding Xu; Chunwu Pan; Min Ye; Jian Kang; Qiang Bai; Jun Qi
Journal:  Exp Ther Med       Date:  2014-07-11       Impact factor: 2.447

Review 7.  Mouse Tumor Models for Advanced Cancer Immunotherapy.

Authors:  Daria S Chulpanova; Kristina V Kitaeva; Catrin S Rutland; Albert A Rizvanov; Valeriya V Solovyeva
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

8.  Establishment of an optimized orthotopic bladder cancer model in mice.

Authors:  Jinming Cai; Zhiwen Xie; Yilin Yan; Zhengnan Huang; Pengfei Tang; Xiangqian Cao; Zeyi Wang; Chenkai Yang; Mingyue Tan; Fang Zhang; Bing Shen
Journal:  BMC Urol       Date:  2022-09-03       Impact factor: 2.090

9.  A new method of establishing orthotopic bladder transplantable tumor in mice.

Authors:  Xi-Hua Yang; Lian-Sheng Ren; Guo-Ping Wang; Li-Li Zhao; Hong Zhang; Zhen-Guo Mi; Xihua Bai
Journal:  Cancer Biol Med       Date:  2012-12       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.